- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
ITL signs rad provider
Image Technology Laboratories of Kingston, NY, has signed Park Avenue Associates in Radiology of Johnson City, NY, to a multisite contract to deploy its ITL WarpSpeed PACS/RIS system. Three outpatient imaging sites will be integrated with both Internet
Image Technology Laboratories of Kingston, NY, has signed Park Avenue Associates in Radiology of Johnson City, NY, to a multisite contract to deploy its ITL WarpSpeed PACS/RIS system. Three outpatient imaging sites will be integrated with both Internet and microwave communication links as part of the installation, which will feature ITL's touchscreen-controlled view stations in radiology facilities, hospitals, and several referring physician practices. The five-year contract calls for the installation of ITL's integrated PACS/RIS solution with automated workflow enhancing modules. The 21-physician-member Park Avenue Associates provides imaging and radiologic services in southern New York State.
FDA Approves Fluorescence Imaging System for Detecting Residual Breast Cancer
April 18th 2024The combination of the optical imaging agent Lumisight and the fluorescence imaging device Lumicell Direct Visualization System, collectively known as LumiSystem, reportedly offers 84 percent accuracy with real-time detection of residual breast cancer after lumpectomy procedures.
Study of Ofatumumab for Multiple Sclerosis Shows 'Profoundly Suppressed MRI Lesion Activity'
April 17th 2024The use of continuous ofatumumab in patients within three years of a relapsing multiple sclerosis diagnosis led to substantial reductions in associated lesions on brain MRI scans, according to research recently presented at the American Academy of Neurology (AAN) conference.
Could a Deep Learning Model for Mammography Improve Prediction of DCIS and Invasive Breast Cancer?
April 15th 2024Artificial intelligence (AI) assessment of mammography images may significantly enhance the prediction of invasive breast cancer and ductal carcinoma in situ (DCIS) in women with breast cancer, according to new research presented at the Society for Breast Imaging (SBI) conference.
